ClinConnect ClinConnect Logo
Search / Trial NCT06891313

One Stage Ridge Splitting Using 2 Different Techniques in the Posterior Mandible

Launched by CAIRO UNIVERSITY · Mar 17, 2025

Trial Information

Current as of May 09, 2025

Not yet recruiting

Keywords

Ridge Augmentation One Stage Ridge Splitting In Posterior Mandible. Piezo Surgery

ClinConnect Summary

This clinical trial is studying two different methods for a dental procedure called ridge splitting, which is used to prepare the jawbone for dental implants. The trial will compare a traditional technique to a newer approach using a special tool called piezo surgery. Both methods aim to help patients who have lost bone in their lower jaw and need it rebuilt for successful dental implants.

To participate in this trial, patients need to have enough bone height and width in the jaw, at least one missing tooth, and may have previously experienced failed dental implants. The trial is not open yet, but when it is, participants can expect to undergo imaging tests before the procedure, receive local anesthesia, and have a surgical process that includes bone preparation and implant placement. After four months, follow-up imaging will check the results. It’s important to know that certain health conditions, like uncontrolled diabetes or recent cancer treatments, will exclude potential participants to ensure safety during the trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with mandibular residual alveolar bone height not less than 8 mm.
  • Alveolar bone width from 5mm to 3mm.
  • Both genders.
  • At least single missing tooth.
  • Previous failed implants.
  • Tapered or cylinder cross sectioned alveolar bone defect pattern.
  • Exclusion Criteria:
  • Heavy smokers more than 20 cigarettes per day.
  • Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
  • Patients had radiotherapy and chemotherapy in head and neck.
  • Patients had neoplasms in sites to be grafted.
  • Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
  • Pregnant females.
  • Patients with Para functional habits, apprehensive and non-cooperative.
  • Bone pathology related to the site to be grafted.
  • Psychological problems, stress situation (socially or professionally), emotional instability, and unrealistic patients' expectations.
  • Intraoral soft and hard tissue pathology.
  • Systemic condition that contraindicates implant placement.
  • Under the age of 18 years.
  • Hourglass defects or defects with bone concavities and or undercuts.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported